Microban Helps Medical Manufacturers Address HAIs

Article

Microban International, a global leader in built-in antimicrobial product protection, announced today a new initiative designed to help medical device manufacturers get to market quicker with antimicrobial solutions for 510(k) registered medical devices used in hospitals and other healthcare facilities.

Helthcare-acquired infections (HAIs) are responsible for approximately 100,000 deaths per year and incur in excess of $20 billion in healthcare costs. "Our expertise utilizing a breadth of antimicrobial technologies enables us to help manufacturers of medical devices develop safer and more effective antimicrobial solutions for their products and provides an important resource to help address the growing concern over hospital acquired infections," said David Meyers, president and CEO of Microban International.

Microban has an extensive portfolio of organic, inorganic and organometallic antimicrobial technologies which enable it to choose the optimal technology for the device. It works closely with customers to engineer antimicrobial solutions that are designed to meet the specific needs of each unique device application, evaluating important criteria such as: antimicrobial performance utilizing industry standard protocols and testing for specific microorganisms and relevant kill times; durability requirements and exposure time periods; product usage environment; manufacturing parameters; and necessary regulatory approvals.

With more than 20 years of experience engineering antimicrobial solutions across a breadth of product applications and materials including expertise with thermoplastics, cross-linked thermosets, coatings and textiles Microban says it can help medical device manufacturers to more effectively and accurately screen and optimize potential antimicrobial technologies.  In addition, its onsite state-of-the-art microbiology laboratory utilizes a high throughput quantitative testing system that enables Microban to quickly and reliably deliver accurate data and proof of concept studies.

Microban offers full service support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  For more information, medical manufacturers should visit http://www.microban.com/microban-medical.

 

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content